文章 作者 回复 / 人气 最后发表

Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation

xfcaiii
2016-12-15
1 / 710 2016-12-15 15:43
by: szm

Association of HLA-DRB1 gene polymorphisms with hepatocellular carcinoma risk: a meta-analysis.

liuli315
2016-12-15
0 / 903 2016-12-15 09:59
by: liuli315

Genetic modifications associated with ketogenic diet treatment in the BTBRT+Tf/J mouse model of auti

xaken
2016-12-14
2 / 1168 2016-12-15 09:52
by: xaken

Bloodstream infections during the first year after pediatric small bowel transplantation.

wow99wow
2016-12-14
1 / 711 2016-12-15 09:38
by: szm

Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review

wow99wow
2016-12-14
1 / 745 2016-12-15 09:36
by: szm

The microbiological and clinical analysis of bloodstream infections with identifiable sources

wow99wow
2016-12-14
1 / 753 2016-12-15 09:34
by: szm

Clinical characteristics and risk factors for fatality in patients with bloodstream infections cause

wow99wow
2016-12-14
1 / 765 2016-12-15 09:29
by: szm

The selective noradrenaline re-uptake inhibitor reboxetine has an early onset of antidepressant acti

geffery
2016-12-15
1 / 1083 2016-12-15 09:24
by: szm

Efficacy and tolerability of venlafaxine and fluoxetine in outpatients with major depression.

geffery
2016-12-15
1 / 973 2016-12-15 09:20
by: szm

Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression.

geffery
2016-12-15
1 / 1006 2016-12-15 09:13
by: szm

Urinary system as a primary source of bloodstream infection

wow99wow
2016-12-14
0 / 554 2016-12-14 20:30
by: wow99wow

Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.

geffery
2016-12-14
1 / 1015 2016-12-14 16:57
by: szm

Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled tri

geffery
2016-12-14
1 / 1029 2016-12-14 16:53
by: szm

Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care:  a random

geffery
2016-12-14
1 / 1041 2016-12-14 16:52
by: szm

Mirtazapine compared with paroxetine in major depression.

geffery
2016-12-14
1 / 1005 2016-12-14 16:41
by: szm

Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes

geffery
2016-12-14
1 / 954 2016-12-14 16:40
by: szm

Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertalin

geffery
2016-12-14
0 / 797 2016-12-14 15:23
by: geffery

Determination of the dose of agomelatine, a melatoninergic agonist and selective  5-HT(2C)

geffery
2016-12-14
0 / 593 2016-12-14 15:13
by: geffery

wiley 1

( -100 )
decipherer
2016-12-14
1 / 885 2016-12-14 15:06
by: szm

sciencedirect 1

decipherer
2016-12-14
1 / 672 2016-12-14 15:01
by: szm

【求助】 springer 1

decipherer
2016-12-14
1 / 635 2016-12-14 14:59
by: szm

bioscience 1

decipherer
2016-12-14
0 / 551 2016-12-14 14:17
by: decipherer

nature.1

decipherer
2016-12-14
0 / 419 2016-12-14 14:06
by: decipherer

Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine

geffery
2016-12-14
1 / 771 2016-12-14 12:14
by: szm

Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-contr

geffery
2016-12-14
1 / 678 2016-12-14 12:10
by: szm
版块权限查看
在线用户:共0人在线,0位会员(0位隐身)

开放主题    热门主题    锁定主题    关闭主题    投票主题    锁定投票
分享:

愚愚学园属于纯学术、非经营性专业网站,无任何商业性质,大家出于学习和科研目的进行交流讨论。

如有涉侵犯著作权人的版权等信息,请及时来信告知,我们将立刻从网站上删除,并向所有持版权者致最深歉意,谢谢。